Overview
Hereditary retinoblastoma is a type of eye cancer that develops in the retina, the light-sensitive tissue at the back of the eye. It is caused by an inherited change (mutation) in the RB1 gene, which normally acts as a tumor suppressor — meaning it helps prevent cells from growing out of control. When a child inherits a faulty copy of this gene from a parent, every cell in their body carries that mutation, making them much more likely to develop tumors in one or both eyes, usually before the age of five. The most common early sign is a white glow in the pupil of the eye, often noticed in photographs taken with a flash. This is sometimes called "cat's eye reflex" or leukocoria. Other signs include crossed eyes (strabismus), redness, swelling, or vision problems. Because the mutation is present in all cells, children with hereditary retinoblastoma often develop tumors in both eyes and may also be at increased risk for other cancers later in life, such as bone cancer (osteosarcoma) or soft tissue sarcomas. Treatment depends on the size and location of the tumors and whether one or both eyes are affected. Options include chemotherapy (given through a vein, directly into the eye, or into the artery feeding the eye), laser therapy, cryotherapy (freezing treatment), radiation therapy, and in some cases surgical removal of the eye (enucleation). With early detection and modern treatments, survival rates are very high — over 95% in developed countries. Lifelong monitoring is essential because of the risk of new tumors and second cancers.
Key symptoms:
White glow or reflection in the pupil (leukocoria)Crossed eyes or misaligned eyes (strabismus)Redness or swelling of the eyePoor vision or vision lossEye painDifferent-colored irises (heterochromia)Enlarged pupilBulging of the eye in advanced casesTumors in both eyes (bilateral involvement)Failure to track objects with the eyesIncreased risk of second cancers later in life (bone cancer, soft tissue sarcoma, melanoma)
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Infantile
Begins in infancy, roughly 1 month to 2 years old
FDA & Trial Timeline
10 eventsUniversity of Washington
Eye & ENT Hospital of Fudan University — EARLY_PHASE1
Targeted Therapy Technologies, LLC — PHASE2
Eye & ENT Hospital of Fudan University — EARLY_PHASE1
Amsterdam UMC, location VUmc
Amsterdam University Medical Center
Children's Oncology Group — PHASE2
Institut Curie — PHASE2, PHASE3
French Africa Pediatric Oncology Group
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Hereditary retinoblastoma.
20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary retinoblastoma.
Community
No community posts yet. Be the first to share your experience with Hereditary retinoblastoma.
Start the conversation →Latest news about Hereditary retinoblastoma
Disease timeline:
New recruiting trial: Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Topotecan and Melphalan for Retinoblastoma
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Retinoblastoma Phase II Expanded Access Clinical Trial
A new clinical trial is recruiting patients for Hereditary retinoblastoma
New recruiting trial: Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
A new clinical trial is recruiting patients for Hereditary retinoblastoma
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the exact RB1 mutation in my child, and should other family members be tested?,What treatment plan do you recommend, and what are the chances of saving my child's vision?,How often will my child need eye exams under anesthesia, and for how long?,What is my child's risk of developing second cancers, and what screening should be done throughout their life?,Are there clinical trials or newer treatments available that might benefit my child?,What support services are available for our family, including genetic counseling and psychological support?,If we plan to have more children, what are the chances they will also have this condition, and what prenatal testing options exist?
Common questions about Hereditary retinoblastoma
What is Hereditary retinoblastoma?
Hereditary retinoblastoma is a type of eye cancer that develops in the retina, the light-sensitive tissue at the back of the eye. It is caused by an inherited change (mutation) in the RB1 gene, which normally acts as a tumor suppressor — meaning it helps prevent cells from growing out of control. When a child inherits a faulty copy of this gene from a parent, every cell in their body carries that mutation, making them much more likely to develop tumors in one or both eyes, usually before the age of five. The most common early sign is a white glow in the pupil of the eye, often noticed in phot
How is Hereditary retinoblastoma inherited?
Hereditary retinoblastoma follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hereditary retinoblastoma typically begin?
Typical onset of Hereditary retinoblastoma is infantile. Age of onset can vary across affected individuals.
Are there clinical trials for Hereditary retinoblastoma?
Yes — 20 recruiting clinical trials are currently listed for Hereditary retinoblastoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Hereditary retinoblastoma?
25 specialists and care centers treating Hereditary retinoblastoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.